The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
|Articles|October 2, 2019
- Pharmaceutical Technology-10-02-2019
- Volume 43
- Issue 10
Multi-Shaft Mixers for High-Quality Gels and Creams
VersaMix Multi-Shaft Mixers from Ross utilize a proprietary powder induction feature for charging of thickeners to produce high-quality gels, creams, and pastes.
VersaMix Multi-Shaft Mixers from Ross utilize a proprietary powder induction feature for charging of thickeners to produce high-quality gels, creams, and pastes. The mixer comes equipped with a three-winged anchor, a high-speed disperser blade that provides combinations of shear and bulk flow at various stages of the mixing cycle, and a rotor/stator emulsifying head that highlights the Solids/Liquid Injection Manifold (SLIM) Technology for sub-surface raw material additions.
Available in laboratory and productions sizes up to 2000 gallons, the mixer features lubricant-free shaft seals, an 11-inch touch screen, and a recipe system for batching based on speed, time, temperature, and vacuum level.
Articles in this issue
about 7 years ago
FT-IR Spectrometerabout 7 years ago
Nexera Prep Seriesabout 7 years ago
Pharmaceutical Cleanroom Monitoringabout 7 years ago
Stability Testing for Small-Molecule Clinical Trial Materialsabout 7 years ago
Image Repair Must Get to the Root Causeabout 7 years ago
The Never-Ending Brexit?about 7 years ago
Out with the Old and In with the New European Commissionabout 7 years ago
Data Integrity Violations Draw Strong FDA Rebukesabout 7 years ago
The Fundamentals of Dissolution Testingabout 7 years ago
Overcoming Bioavailability ‘Roadblocks’ with LBDDSRelated to this article
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma AI policies require.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.